Naratriptan

Test Ligands Values Explained

Test Ligand ID - A unique identifier for the test ligand
Ligand Name - Name of the test ligand

Test Ligand ID1291
Ligand NameNaratriptan
PubMed Compound Id4440
StructureProduct Image
Molecular FormulaC17H25N3O2S
Molecular Weight335.5
SMILESCNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C
Synonymsnaratriptan
121679-13-8
N-methyl-2-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]ethanesulfonamide
naratriptanum
N-methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide
UNII-QX3KXL1ZA2
QX3KXL1ZA2
CHEBI:7478
N-methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide
DTXSID7023354
N-Methyl-2-(3-(1-methylpiperidin-4-yl)-1H-indol-5-yl)ethanesulfonamide
N-methyl-2-(3-(1-methyl-4-piperidyl)-1H-indol-5-yl)-ethanesulfonamide
DTXCID003354
N02CC02
N-methyl-3-(1-methyl-4-piperidinyl)-1H-indole-5-ethanesulfonamide
Naramig
1H-Indole-5-ethanesulfonamide, N-methyl-3-(1-methyl-4-piperidinyl)-
Naratriptan (INN)
CHEMBL1278
Colatan
NARATRIPTAN [INN]
N-methyl-2-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]ethane-1-sulfonamide
Naramig (TN)
NCGC00181786-01
Naratriptan [INN:BAN]
NARATRIPTAN [MI]
GTPL45
NARATRIPTAN [VANDF]
SCHEMBL68753
NARATRIPTAN [WHO-DD]
BIDD:GT0312
NARATRIPTAN [ORANGE BOOK]
HY-B0197
BDBM50073682
AKOS015895854
AC-5013
BCP9000978
DB00952
NCGC00181786-03
NCGC00181786-04
NCGC00181786-08
FN170148
TS-09866
5376B
NS00006374
C07792
D08255
G78311
AB01565792_02
EN300-18567334
L000432
Q421315
BRD-K61337602-003-02-1
BRD-K61337602-003-03-9
N-Methyl-3-(1-methyl-4 -piperidinyl)-1H-indole-5-ethansulphonamide
N-Methyl-3-(1-methyl-4-piperidinyl)-1H-indole-5-ethanesulphonamide
2-[3-(1-Methyl-piperidin-4-yl)-1H-indol-5-yl]-ethanesulfonic acid methylamide
InChI=1/C17H25N3O2S/c1-18-23(21,22)10-7-13-3-4-17-15(11-13)16(12-19-17)14-5-8-20(2)9-6-14/h3-4,11-12,14,18-19H,5-10H2,1-2H
Naratriptan; 1H-Indole-5-ethanesulfonamide, N-methyl-3-(1-methyl-4-piperidinyl)-; N-Methyl-3-(1-methyl-4-piperidinyl)-1H-indole-5-ethanesulfonamide; N-Methyl-3-(1-methyl-4-piperidyl)indole-5-ethanesulfonamide; Naratriptan
Created AtJan 13, 2025 2:47 pm
Updated AtJan 13, 2025 2:47 pm